CLOs on the Move

Cardiovascular Systems, Inc.

www.csi360.com

 
Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Our primary focus is helping physicians conquer even the most difficult disease states, including arterial calcium, given the complications it presents for the millions who suffer from peripheral arterial disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe, effective, economical medical devices that improve patient outcomes.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.csi360.com
  • 1225 Old Highway 8 NW
    Saint Paul, MN USA 55112
  • Phone: 651.259.1600

Executives

Name Title Contact Details

Similar Companies

ESA Biosciences

ESA Biosciences is a Chelmsford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioHorizons

BioHorizons is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Z-Sciences Corp

Z-Sciences Corp is a Westmount, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

GenMark Diagnostics

In 1993, a novel technology was invented by a team that included Jon Faiz Kayyem, PhD at The California Institute of Technology (CalTech). This invention combined nucleic acids and microelectronics to produce an electronic sensor for DNA detection. His invention was based on electrical detection of nucleic acids on a cassette based detection platform. Dr. Kayyem went on to found Clinical Micro Sensors, with the goal of translating this “eSensor” technology to disposable chips. Following several acquisitions of the technology, Dr. Kayyem became actively involved again in 2009, returning as an investor and then as CEO and Chairman of the Board. In 2009, a collaboration between Dr. Kayyem and Christopher Gleeson began. The two redefined the company strategy, and brought in a new board of directors, executive leadership team, and commercial management. In 2010, the company known at that time as Osmetech, was named GenMark Diagnostics and listed on NASDAQ. Mr. Gleeson remained an integral part of GenMark`s growth in the years that followed, serving as Chairman of the Board until his retirement in 2014. Dr. Kayyem currently serves as SVP, Research and Development.

venus-concept

Venus Concept is a leading developer and manufacturer of devices for the medical aesthetic market.